Related Articles
Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells
miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma
The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells
Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix